Clinical trial

Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration

NCT00187135 · St. Jude Children's Research Hospital, Other · Terminated

Key facts

NCT number NCT00187135
Title Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration
Official title Fentanyl-Propofol-EMLA or L.M.X4™ Technique for Bone Marrow Aspiration in Pediatric Patients - A Phase III Study
Lead sponsor St. Jude Children's Research Hospital, Other
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Bone Marrow Disease, Pain
Intervention type Drug
Interventions Fentanyl, EMLA, L.M.X4, Propofol
Enrollment 168
Start date Mar 1, 2002
Primary completion Aug 1, 2008
Completion Aug 1, 2008
First posted Sep 16, 2005
Last update posted Apr 4, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies